Navigation Links
Hormone Shows Potential as Diabetes Treatment in Mice
Date:4/25/2013

THURSDAY, April 25 (HealthDay News) -- A hormone that could lead to more effective diabetes treatment has been identified by researchers.

The hormone, called betatrophin, causes mice to produce insulin-secreting pancreatic beta cells at up to 30 times the normal rate. But it only produces insulin when the body needs it, according to the team at the Harvard Stem Cell Institute.

The researchers said their findings offer the potential for the natural regulation of insulin and a significant reduction in diabetes-related complications such as blindness and limb amputation.

The study is published in the April 25 online edition of the journal Cell and in its May 9 print issue.

Although the hormone shows promise in lab mice, much more work is needed before it could be considered as a treatment for diabetes in humans, the researchers noted. Results obtained in animal experiments often aren't attainable in trials with humans.

"If this could be used in people, it could eventually mean that instead of taking insulin injections three times a day, you might take an injection of this hormone once a week or once a month, or in the best case maybe even once a year," Doug Melton, co-director of the institute and co-chair of Harvard University's department of stem cell and regenerative biology, said in a university news release.

About 26 million Americans have type 2 diabetes, which causes people to slowly lose beta cells and the ability to produce sufficient amounts of insulin.

"Our idea here is relatively simple," Melton said. "We would provide this hormone, the type 2 diabetic will make more of their own insulin-producing cells, and this will slow down, if not stop, the progression of their diabetes. I've never seen any treatment that causes such an enormous leap in beta cell replication."

Along with its potential for treating type 2 diabetes, betatrophin might also have a role in treating type 1 diabetes, Melton said.

Unlike type 2 diabetes, which is associated with being overweight and sedentary, type 1 diabetes is an autoimmune disease that occurs most often in children and young adults.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diabetes.

-- Robert Preidt

SOURCE: Harvard University, news release, April 25, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hormones For Weight Control Article And Video Published by BetterDigestion.org
2. Researchers identify and block protein that interferes with appetite-suppressing hormone
3. Intermittent Hormone Treatment for Prostate Cancer Not the Best
4. Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
5. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
6. More Evidence Shows Hormone Therapy May Increase Breast Cancer Risk
7. Artificial Ovaries Could Potentially Deliver Hormone Therapy
8. Mindfulness from meditation associated with lower stress hormone
9. Should Short Boys Take Growth Hormone?
10. Hormone Pills in Menopause May Carry Gallstone Side Effects
11. Study examines outcomes of screening mammography for age, breast density, hormone therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Shows Potential as Diabetes Treatment in Mice
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced two key appointments ... company’s continued investment and strategic growth plans in the Asia Pacific region. , ...
(Date:5/26/2016)... ... ... an effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi ... use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all ... Dr. Mohebi says, “The positive response to the Snapchat videos we started last month has ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... treatment for eating disorders, is opening a brand new child and adolescent residential ... 8-17 and their families with even more specialized eating disorder treatment and access ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... India , May 25, 2016 ... Animation Market by Type (3D, 2D, 4D), by Therapeutic ... Education), by End User (Medical Device Manufacturers, Hospitals/ Clinics) ... studies the global Medical Animation Market for the forecast ... to reach USD 301.3 Million by 2021 from USD ...
Breaking Medicine Technology: